CClinicalTrials.gg
Sign In
Status unknownNCT01832246Updated Nov 18, 2014

Endoscopic Ultrasonographic Staging and Conventional Endoscopic Staging for Depth of Invasion for Early Gastric Cancer

An observational study in Gastric Tumor and Early Gastric Cancer, sponsored by Seoul National University Hospital. Status unknown at 1 site in Korea, Republic of. Open to participants aged 20 Years to 80 Years. Per ClinicalTrials.gov, last updated 2014-11-18.

Sponsored by Seoul National University Hospital · Observational

The sponsor has not verified this record recently (last verified Nov 2014), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
560
Ages
20 Years to 80 Years
Sex
All
01

Study summary

The accurate prediction of depth of tumor invasion in early gastric cancer is essential for the proper selection of candidates for endoscopic resection. Conventional endoscopy and endoscopic ultrasonography have been useful diagnostic method for depth of invasion in early gastric cancer. However, there has been no prospective comparative study on the accuracy between the 2 methods. Therefore, the investigators prospectively compare the accuracy between the 2 methods regarding prediction of depth of invasion.

02

Conditions studied

  • Gastric Tumor
  • Early Gastric Cancer

Browse trials for

Keywords

  • endoscopy
  • endosonography
  • stomach cancer
  • tumor staging
03

In context

Stomach Neoplasms

2,851 studies on the registry are indexed under Stomach Neoplasms; 864 are open to participants now.

This study's planned enrollment of 560 is above the median of 274 across 670 observational studies indexed under Stomach Neoplasms.

Browse Stomach Neoplasms studies →

Lead sponsor

Seoul National University Hospital is the lead sponsor of 1,860 studies on the registry; 275 are open to participants now.

Of its 12 completed or terminated interventional studies of FDA-regulated products, 2 (17%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

patients with early gastric adenocarcinoma is prospectively enrolled at Seoul National University Hospital.

Inclusion criteria

  • Patients with early gastric adenocarcinoma undergo both endoscopic staging and endoscopic ultrasonographic staging for depth of invasion

Exclusion criteria

Exclusion Criteria:

  • patients had previously received neoadjuvant chemotherapy or chemoradiotherapy
  • patients with obviously advanced gastric cancer by endoscopy
  • the evidence of distant metastasis or extensive adjacent organ invasion on abdominal CT scan
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
560 participants (estimated)
06

What researchers measure

Primary outcomes

  1. diagnostic accuracy between endoscopic ultrasonographic staging and conventional endoscopic staging

    Time frame: up to 2.5 years (end of study, December 2014)

07

Study locations

1 site
  • Division of Gastroenterology, Department of Internal Medicine and Liver Research Institute, Seoul National University Hospital
    Seoul, 110-744, Korea, Republic of
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 18, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01832246
Lead sponsor
Seoul National University Hospital
Responsible party
Jeongmin Choi (professor, Department of Internal Medicine and Liver Research Institute, Seoul National University Hospital) — Principal investigator
First posted
Apr 16, 2013
Start date
Dec 2014
Primary completion
Dec 2015 (estimated)
Completion
Dec 2015 (estimated)
Last update
Nov 18, 2014

Study contacts

Jeongmin Choi, M.D.
Contact
doct00@hanmail.net
82-2-2072-7209
Sang Gyun Kim, M.D.
study director · Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine
Jeongmin Choi, M.D.
principal investigator · Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Stomach Neoplasms→

Other studies from this sponsor

Seoul National University Hospital

Start the discussion